Clinical trials
Bronchiectasis clinical trials
Below are recruiting bronchiectasis clinical trials, each written for real people, not researchers. We’re tracking 82 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07283497RecruitingPhase 4
Itraconazole for bronchiectasis with airway mold growth
This Mayo Clinic study tests whether the oral antifungal drug itraconazole can help people with bronchiectasis who have mold growing in their airways. The goal is to see if it improves symptoms and reduces mold in the lungs.
Rochester, MinnesotaAges 18 years+ - NCT06760273Recruiting
Tobramycin for Pseudomonas infection in bronchiectasis
This study looks at the long-term effects of using an inhaled antibiotic called tobramycin to get rid of Pseudomonas aeruginosa bacteria in people with bronchiectasis. It may help keep the infection away and improve breathing health.
Hefei, AnhuiAges 18–80 - NCT07201051RecruitingPhase 2
Testing a new drug for people with bronchiectasis
This trial tests if a new drug, GSK3862995B, is safe and effective for adults with bronchiectasis. It might help reduce lung infections and improve symptoms.
Mobile, AlabamaAges 18–85 - NCT07188675Recruiting
Breathing muscle training for bronchiectasis
This trial tests whether a special breathing exercise device can help people with bronchiectasis. You may qualify if you are between 18 and 30, have been diagnosed with bronchiectasis, and are feeling stable.
IstanbulAges 18–30 - NCT03561818Recruiting
Home or hospital physiotherapy for bronchiectasis efficiency
This study compares how well breathing/airway physiotherapy works when done at home versus in a hospital for people with bronchiectasis. It may help determine which approach is easier and works best while you’re stable.
Istanbul, ZeytinburnuAges 18–75 - NCT07135284Recruiting
Testing the LibAirty System for Bronchiectasis at Home
This trial tests the LibAirty system, a device that helps clear mucus from your lungs, in people with bronchiectasis. Participants use the device at home to see how well it works in daily life.
Birmingham, AlabamaAges 21 years+ - NCT07121218Recruiting
Physical fitness in children with bronchiectasis
This trial measures physical fitness levels in children with bronchiectasis. It aims to understand how the condition affects fitness and may help guide future care.
Istanbul, FatihAges 7–18 - NCT07114120RecruitingPhase 4
Bailing capsules and Guben Kechuan granules for stable bronchiectasis
This trial tests whether two Chinese herbal medicines, Bailing capsules and Guben Kechuan granules, can help people with stable bronchiectasis. It aims to reduce flare-ups and improve lung function.
Hangzhou, ZhejiangAges 18–80 - NCT07104942Recruiting
Breathing muscle strength in bronchiectasis
This trial tests whether a breathing muscle exercise can help people with bronchiectasis breathe easier. It looks at how the exercise affects your ability to cough and clear mucus.
IstanbulAges 18–65 - NCT07088926RecruitingPhase 2
Study of a new drug for bronchiectasis with chronic pseudomonas infection
This study tests an investigational drug given through an IV to see if it can reduce lung infections and flare-ups in people with bronchiectasis who have a chronic pseudomonas infection. Participation may help improve symptoms and quality of life.
Orange, CaliforniaAges 12 years+ - NCT07048262RecruitingPhase 2
Study of an inhaled drug for adults with non-CF bronchiectasis
This trial tests an inhaled medication called CSL787 to see if it can help people with non-cystic fibrosis bronchiectasis (a lung condition that causes frequent infections and breathing problems). The study looks at different doses and checks how well the drug works and if it is safe.
QueenslandAges 18–85 - NCT06987214RecruitingPhase 1
Regenerative stem cell therapy for bronchiectasis
This trial tests whether transplanting your own lung stem cells can repair damaged airways caused by bronchiectasis. It is for people with moderate to severe breathing impairment and aims to improve lung function.
Qionghai, HainanAges 25–80 - NCT06900062Recruiting
Bronchiectasis Research Study at Shanghai Hospital
This study looks at the genes and health data of people with bronchiectasis to better understand the disease. It may help find new ways to treat or manage your condition.
Guiyang, GuizhouAges 18–85 - NCT06897761Recruiting
A digital game to help children with bronchiectasis breathe better
This trial tests a fun interactive game and device to help children with bronchiectasis improve their breathing and lung health. It is designed for children who are stable and have not had recent infections or treatments.
IstanbulAges 7–18 - NCT06872892RecruitingPhase 3
Study of BI 1291583 for people with bronchiectasis
This trial tests whether a new medication, BI 1291583, can help people with bronchiectasis reduce lung infections and symptoms. You may join if you have had at least one or two lung flare-ups in the past year.
Birmingham, AlabamaAges 12 years+ - NCT06625944Recruiting
How viral infections affect lung disease
This study looks at how viral infections impact people with chronic lung conditions like COPD or bronchiectasis. It aims to understand symptoms and triggers better, which could help improve future treatments.
LondonAges 18 years+ - NCT06209047RecruitingPhase 4
Antibiotics via bronchoscopy for bronchiectasis flare-ups
This study tests if giving antibiotics (levofloxacin or gentamicin) directly into the lungs during a bronchoscopy can help patients with bronchiectasis who are in the hospital with a sudden worsening of symptoms or are on a breathing machine.
AsyutAges 18 years+ - NCT06801327Recruiting
Comparing two breathing therapies for bronchiectasis
This trial tests whether a new device called Simeox works better than standard chest physical therapy for people with bronchiectasis (widened airways that trap mucus). It compares how well each method clears mucus from the lungs.
Bologna, BolognaAges 18 years+ - NCT06242795RecruitingPhase 4
Hypertonic saline for non-cystic fibrosis bronchiectasis
This trial tests whether inhaling a saltwater solution (hypertonic saline) twice a day for 12 weeks can help people with bronchiectasis who have a chronic cough and have had flare-ups in the past. It aims to see if this treatment reduces mucus and improves quality of life.
Chapel Hill, North CarolinaAges 18 years+ - NCT06346938Recruiting
CT scan markers for bronchiectasis classification and outlook
This study looks at whether CT scan features can help doctors better classify bronchiectasis and predict how the disease may progress. It aims to improve understanding of the condition to guide treatment decisions.
Wuhan, HubeiAges 18–100 - NCT06631261Recruiting
Stepper test for lung and heart health in bronchiectasis
This study compares how the heart and lungs respond to a 6-minute stepper exercise in people with bronchiectasis versus healthy adults. It aims to better understand the physical impact of bronchiectasis on daily activities.
AnkaraAges 18 years+ - NCT06559150RecruitingPhase 2
Study of ensifentrine for non-cystic fibrosis bronchiectasis
This trial tests an inhaled drug called ensifentrine in people with bronchiectasis (damaged, widened airways in the lungs). The goal is to see if it can reduce flare-ups and improve symptoms.
Birmingham, AlabamaAges 18–80 - NCT06487273Recruiting
SIMEOX device for mucus clearance at home in bronchiectasis
This study tests a home-use device called SIMEOX, which helps clear mucus from your lungs. It is for adults with bronchiectasis (not cystic fibrosis) who have frequent lung infections.
AbbevilleAges 18 years+ - NCT06368804RecruitingPhase 2
Comparing two antibiotics for early PA infection in bronchiectasis
This trial tests two different antibiotic treatments for adults with bronchiectasis who have a new or recent infection with Pseudomonas aeruginosa (PA) bacteria in their airways. The goal is to see which regimen works better to clear the infection early.
AmiensAges 18 years+
Hear when a new Bronchiectasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for bronchiectasis?
- Yes. Clin2 currently lists 82 recruiting bronchiectasis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a bronchiectasis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a bronchiectasis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.